We are live on ! Find out more
BBNX

Beta Bionics

158 hedge funds and large institutions have $1.44B invested in Beta Bionics in 2025 Q4 according to their latest regulatory filings, with 46 funds opening new positions, 61 increasing their positions, 30 reducing their positions, and 16 closing their positions.

New
Increased
Maintained
Reduced
Closed

188% more first-time investments, than exits

New positions opened: 46 | Existing positions closed: 16

103% more repeat investments, than reductions

Existing positions increased: 61 | Existing positions reduced: 30

50% more capital invested

Capital invested by funds: $963M → $1.44B (+$477M)

22% more funds holding

Funds holding: 129158 (+29)

0% more funds holding in top 10

Funds holding in top 10: 55 (0)

3.96% less ownership

Funds ownership: 111.22%107.26% (-4%)

Holders
158
Holders Change
+29
Holders Change %
+22.48%
% of All Funds
1.92%
Holding in Top 10
5
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
0.06%
New
46
Increased
61
Reduced
30
Closed
16
Calls
$320K
Puts
Net Calls
+$320K
Net Calls Change
+$320K
Name Holding Trade Value Shares
Change
Change in
Stake
JF
51
Jump Financial
Illinois
$2.64M +$2.31M +86,504 New
LCM
52
Legato Capital Management
California
$2.61M +$588K +22,035 +35%
N
53
Nuveen
North Carolina
$2.6M +$852K +31,889 +60%
Balyasny Asset Management
54
Balyasny Asset Management
Illinois
$2.59M +$2.2M +82,458 +3,279%
Squarepoint
55
Squarepoint
New York
$2.54M +$2.23M +83,421 New
Verition Fund Management
56
Verition Fund Management
Connecticut
$2.52M +$950K +35,563 +75%
BG
57
Bellevue Group
Switzerland
$2.2M +$214K +8,002 +12%
Holocene Advisors
58
Holocene Advisors
New York
$2.19M +$1.92M +71,777 New
TD Asset Management
59
TD Asset Management
Ontario, Canada
$2.01M +$155K +5,800 +10%
Barclays
60
Barclays
United Kingdom
$1.85M +$167K +6,250 +11%
Mirae Asset Global ETFs Holdings
61
Mirae Asset Global ETFs Holdings
Hong Kong
$1.66M -$19.4K -725 -1%
JFG
62
Jefferies Financial Group
New York
$1.57M +$1.37M +51,400 New
AQR Capital Management
63
AQR Capital Management
Connecticut
$1.54M -$42.9K -1,605 -3%
Wells Fargo
64
Wells Fargo
California
$1.53M +$490K +18,358 +57%
Manulife (Manufacturers Life Insurance)
65
Manulife (Manufacturers Life Insurance)
Ontario, Canada
$1.47M +$108K +4,035 +10%
Osaic Holdings
66
Osaic Holdings
Arizona
$1.47M +$1.23M +46,216 +2,453%
SEI Investments
67
SEI Investments
Pennsylvania
$1.46M +$1.28M +48,074 New
XT
68
XTX Topco
Cayman Islands
$1.34M +$1.17M +43,990 New
LCG
69
Lisanti Capital Growth
New York
$1.31M +$1.15M +42,985 New
RhumbLine Advisers
70
RhumbLine Advisers
Massachusetts
$1.31M -$114K -4,259 -9%
DSCM
71
Divisadero Street Capital Management
Florida
$1.21M +$1.06M +39,606 New
Deutsche Bank
72
Deutsche Bank
Germany
$1.2M +$34.6K +1,296 +3%
Jacobs Levy Equity Management
73
Jacobs Levy Equity Management
New Jersey
$1.14M -$43.2K -1,617 -4%
Calamos Advisors
74
Calamos Advisors
Illinois
$1.1M +$101K +3,789 +12%
AllianceBernstein
75
AllianceBernstein
Tennessee
$1.08M +$291K +10,900 +44%

BBNX Hedge Fund Activity: Q4 2025 in Review

158 of the 8,225 institutional investors tracked by Wall St. Rank reported a position in Beta Bionics (BBNX) for Q4 2025, worth a combined $1.44B — up 50% from $963M a quarter earlier.

Buyers outnumbered sellers: 46 funds opened new BBNX positions and 16 closed out — a net gain of 30 holders — while 61 added to existing stakes and 30 trimmed.

The largest buyer was Healthcare of Ontario Pension Plan (HOOPP) Trust Fund, opening a new position worth an estimated $35.4M. The largest seller was Wellington Management Group, exiting entirely with an estimated $77.5M sold.

  • 158 institutional investors held Beta Bionics (BBNX) as of Q4 2025, up from 129 in Q3 2025.
  • Funds reported $1.44B of Beta Bionics stock for Q4 2025, up 50% quarter-over-quarter.
  • 46 funds opened new Beta Bionics positions in Q4 2025 and 16 closed out, a net change of +30 holders.
  • The largest Beta Bionics buyer in Q4 2025 was Healthcare of Ontario Pension Plan (HOOPP) Trust Fund, an estimated $35.4M added.
  • The largest Beta Bionics seller in Q4 2025 was Wellington Management Group, an estimated $77.5M sold.

Based on aggregated 13F filings for Q4 2025.